Find information on Industry Analysis Report

Posts tagged ‘Drug’

Report on Therapy Trends: Multiple Sclerosis

An incisive report and dynamic analyst briefing service delivering insight from the most influential Multiple Sclerosis (MS) Key Opinion Leaders to map the current treatment landscape and analyse future trends.

Multiple Sclerosis: On the cusp of a treatment revolution
The year 2012 will see landmark changes in the treatment of MS. Gilenya, the first novel drug in five years, is to be joined by three new products; BG-12 from Biogen Idec, Sanofi’s Aubagio and Genzyme’s Lemtrada. These drugs will partially satisfy substantial unmet needs of convenient administration and more efficacious therapy to drive unprecedented market growth.

Driven by in-depth interviews with the world’s leading multiple sclerosis KOLs, Therapy Trends: Multiple Sclerosis uncovers how the current treatment landscape will be impacted by significant future events, with particular focus on pipeline therapies and how these will modify the way MS is managed by neurologists in the future.

Drive your strategic decision-making with inside intelligence

Therapy Trends: Multiple Sclerosis disseminates critical opinion and analysis to provide premier research.
* We cut to the heart of market-changing events and eliminate superfluous background information so you can focus on developments of greatest strategic impact and reduce your reaction time
* Our unique thought-leader selection matrix identifies the most influential KOLs in MS to deliver the perspectives vital in giving you a competitive edge, enabling informed decision-making and planning
* Detailed analysis of marketed and pipeline drugs helps you understand the products that will shape the future MS market
* KOL consensus on the future treatment algorithm offers a window into the future changes in medical evidence and clinical practice
* Uncovering KOLs’ opinions on unmet needs enables you to identify potential commercial opportunities
* Dynamic report updates evaluate the market impact of key events from KOL perspectives, allowing you to react to significant MS market developments within days of events occurring

Critical questions answered
Our MS KOLs are selected according to their level of engagement and influence within the pharmaceutical industry and their scientific standing. FirstWord’s unique KOL scoring system enables identification of KOLs with the greatest knowledge of how MS treatment will evolve and shape the future landscape.

* What are the key unmet needs? There is a high risk, high reward opportunity in the development of a therapy with efficacy for progressive subtypes.
* How will therapies will be positioned against each other in the future of MS treatment? Biogen’s new oral therapy BG-12 is expected to usurp the current market leaders and become the first-line therapy of choice.
* How will treatment developments play out in the near future? Biogen’s activity in broadening its robust pipeline shows its resolve in maintaining its leading position in MS.
* Is there potential for new players in the lucrative MS market? New entrants are set to capture significant share and cannibalise sales of the leading drugs.
* Where will Sanofi’s Lemtrada and Aubagio be positioned in treatment? Pricing and safety will play a large part in determining uptake of this highly effective drug
* How will the launch of biosimilars affect prescribing behavior? Pricing will be a key determinant in positioning and uptake
* How will Novartis’s Gilenya be affected by recent safety concerns? Long-term concerns have kept it from being the first line therapy.
* Will the new John Cunningham Virus test encourage earlier adoption of Tysabri? This offers the first example of personalised medicine; a trend that will aid uptake in future.

For more information kindly visit :
Report on Therapy Trends: Multiple Sclerosis

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
http://3marketresearchreport.blogspot.in/

Report on Consensus Outlook: Multiple Sclerosis

Over the next five years, the global multiple sclerosis (MS) market is set to grow from $12.3 billion in 2011 to $17.3 billion in 2016. Primary drivers of this growth will be the entry of new pipeline therapies, satisfying the unmet needs of convenient administration and more efficacious therapy, and continued uptake of existing therapies.

Therapy Trends Consensus Outlook: Multiple Sclerosis analyses the global MS market players and products of today and tomorrow. Start mapping your market parameters with access to the following comprehensive resources:

* An in-depth 5-year forecast report based on analyst consensus, mapping the impact of future events to predicted product performance
* A detailed forecast data analysis spreadsheet model comparing critical market parameters including market size, product sales, market shares and competitive status over the period 2006 to 2016
* Timely event-driven market forecast report and data analysis updates over the next 12 months

Understand the Unique Benefits of Consensus Outlook
* Evaluate future sales forecasts and predicted market growth
* Map your market parameters and chart commercial prospects
* Assess market share by company and product
* Tailor your strategic and investment focus based on the competition
* Set proactive launch and branding strategies
* Keep up with event-driven market data updates

Mapping Future Events to Product Sales Forecasts
The forecast analysis report component of Consensus Outlook: Multiple Sclerosis delivers a rich analysis of product-level sales forecast data and of the future events that underpin the forecasts. The product of meticulous FirstWord research, its historical sales data (2006–11) is based on company information, and the five-year (2012-16) product level sales forecasts are consensus projections derived from a comprehensive selection of continually assessed equity research reports.

The report combines independent, unbiased, accurate forecasts with invaluable insights into factors that impact future product performance, backed-up by research of analysts who have an unrivalled level of intimacy with the market, the players, their products and their strategies.

Report features:
* Historical MS sales from 2006–2011
* Forecast MS sales from 2012-2016
* Key competitors and drug developers
* Predicted product positioning
* Current and late-stage pipeline drugs
* Future event mapping to forecast data points
* Comparative clinical trial results

An approach backed by unrivalled knowledge and market intimacy
For each Therapy Trends report, FirstWord analysts produce a data analysis module, a Consensus Outlook, which provides annual historical and forecast, product-level sales data. Historical sales data is derived from company information, while the five-year (2012-16) product level sales forecasts are consensus projections derived from a comprehensive selection of continually assessed equity research reports.

Once a Therapy Trends data module is published, FirstWord analysts subsequently collate and evaluate the latest relevant reports published by equity research analysts and feed relevant updated forecasts into the Therapy Trends forecast model.

Consensus forecasts derived from the leading equity research analysts reflect the most up-to-date assessment of the pharmaceutical market, with equity analyst models updated to reflect a broad spectrum of events and catalysts, which range from the publication of quarterly financial results to in-depth discussions with leading key opinion leaders (KOLs). Consensus forecasts also act as an excellent benchmark against which other projections – produced either internally or by other third parties – can be assessed.

For more information kindly visit :
Report on Consensus Outlook: Multiple Sclerosis

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
http://3marketresearchreport.blogspot.in/

Report on Buyer Spend Activity and Procurement Behaviors and Strategies in the Pharmaceutical Industry

• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Analysis on how procurement expenditure, business strategies and practices in the pharmaceutical industry are set to change in 2011–2012.
• Analysis on spending plans, budget allocations, challenges and investment opportunities of purchase decision makers.

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes how procurement expenditure, business strategies and practices are set to change in the pharmaceutical industry in 2012–13. This report gives you access to the category-level spending outlooks, budgets, supplier selection criteria, business challenges and investment opportunities for leading purchase decision makers. The report also identifies future growth of buyers and suppliers and e-procurement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and size.

Scope
• The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey, of which 51% represent Director and C-level respondents.
• The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations.
• The geographical scope of the research is global – drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.
• Key topics covered include buyer expenditure activity, procurement behaviors and strategies, threats and opportunities, economic outlook and business confidence.
• In the report, buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats.
• The report examines current practices and provides future expectations for the industry over the next 12-24 months.

Reasons To Buy
• This report will help you to drive revenues by understanding future product investment areas and growth regions.
• This report will help you to formulate effective sales and marketing strategies by identifying how buyer budgets are changing and the direction of spend in the future.
• This report will help you to better promote your business by aligning your capabilities and business practices with your customer’s changing needs.
• This report will help you to secure stronger customer relationships by understanding the leading business concerns and changing strategies of industry buyers.
• This report will help you to predict how the industry will grow, consolidate and where it will stagnate.
• This report will help you to uncover the business outlook, key challenges and opportunities identified by suppliers and buyers.

Table of Contents
1 Introduction
1.1 What is This Report About?
1.2 Definitions
1.3 Methodology
1.4 Profile of Survey Respondents: Global Pharmaceutical Industry
1.4.1 Profile of buyer respondents: global pharmaceutical industry
1.4.2 Profile of supplier respondents: global pharmaceutical industry
2 Executive Summary
3 Global Pharmaceutical Industry Buyer Spend Activity
3.1 Global Pharmaceutical Industry: Annual Procurement Budgets
3.1.1 Global pharmaceutical industry: annual procurement budgets by company type
3.1.2 Global pharmaceutical industry: annual procurement budgets by region
3.1.3 Global pharmaceutical industry: annual procurement budgets by company turnover
3.2 Global Pharmaceutical Industry: Planned Change in Procurement Spend
3.2.1 Global pharmaceutical industry: planned change in procurement spend by buyer type
3.2.2 Global pharmaceutical industry: planned change in procurement spend by region
3.2.3 Global pharmaceutical industry: planned change in procurement spend by company turnover
3.2.4 Global pharmaceutical industry: planned change in expenditure vs. revenue growth optimism
3.2.5 Global pharmaceutical industry: planned change in expenditure vs. cost containment
3.2.6 Global pharmaceutical industry: planned change in procurement spend – cross industry comparisons

For more information kindly visit :
Report on Buyer Spend Activity and Procurement Behaviors and Strategies in the Pharmaceutical Industry

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
http://3marketresearchreport.blogspot.in/

Report on Understanding South Korean Regional Health Markets

South Korea is one of the more dynamic and advanced Asian medical markets with a well established health infrastructure and national health insurance system. Trends in South Korean society, however, present opportunities for medical and pharmaceutical companies. Notably the country’s increasing aged population which stands at 11% of the population is set to reach 20% by 2025. In addition, a push for a slice of the growing global health tourist trade is just one driver in the expansion of advanced facilities.

Identifying opportunities in South Korea’s valuable and rapidly expanding health economy requires detailed knowledge of the economic performance, health infrastructure and health personnel distribution at a state/territory level. Being able to see that in the context of neighbouring provinces and the national picture brings focus to areas of opportunity and need.

Rich in statistics, charts and maps, this new report (June 2012) Understanding Regional South Korean Health Markets takes you further into understanding the dynamic regional health sector. A comprehensive introduction sets the national scene while summary data for each region highlights the key economic characteristics and health infrastructure. Comparative statistics are provided for each region and can be seen in the light of national averages.

How is the population and wealth regionally distributed?
Which provinces produce the highest levels of GDP?
How is the aging population changing the nature of health provision and long-term care?
What is the primary and secondary health infrastructure in each region?
How is healthcare delivered?
What is the changing role played by private/government health provision?Which regions are better provided for and which still need investment?

Access to this report includes the brilliant Espicom Interactive with machine translation into Korean!

Customers can choose print or pdf format but all get access via Espicom Interactive. This report is rich in charts and tables and Espicom Interactive “one click” extraction of data in MS Excel™ and MS PowerPoint™ means you can easily build the data into your own reports and systems and text can be machine translated into 9 different languages – including Korean.

Table of Contents
Summary .7
Geography….8
Political and Economic Background .8
Politics .8
Economy.10
Demography….12
Population….12
Demographic Indicators…15
Births .. 15
Deaths 15
Infant Mortality… 15
Life Expectancy . 15
Morbidity .16
Communicable Diseases 16
HIV/AIDS. 16
Non-communicable Diseases… 18
Cancer… 18
Cardiovascular Disease . 19
Diabetes 19
Mortality ..20
Healthcare Sector22
Organisation 22
Healthcare Funding ….22
Healthcare Delivery ….23
Private Sector …23
First Foreign Owned Hospital to Open in 2013…. 23
Medical Tourism Marketing Legalised .. 23
Jeju Medical Tourism Project 23
Health Expenditure 24
Organisation of Expenditure 24
Public Sector 24
Private Sector…. 24
WHO Estimates of Health Expenditure … 24
Locally-Sourced Expenditure Data 26
Primary Care28
Primary Care Activity ..28
Hospital Facilities…30
Hospital Activity 34
Patient Survey ..36
Surgical Procedures …38
Hospital Outpatient Visits 39
Medical Personnel .40
Regional Data Comparisons…45
Seoul National Capital Area / Sudogwan .46
Gyeonggi Province…. 48

For more information kindly visit :
Report on Understanding South Korean Regional Health Markets

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
http://3marketresearchreport.blogspot.in/

Report on Understanding Regional Chinese Health Markets

Any assessment of China must consider the huge variations to be found in such a populous and geographically diverse country.

How is the population distributed? How is healthcare delivered?
Health funding: Who pays, who gets?
What are the real effects of the urban/rural divide on health provision?
Which regions are better provided for and which still need investment?

Identifying opportunities in China’s rapidly expanding health economy requires detailed knowledge of the economic performance and health infrastructure at a regional level. Being able to see that in the context of neighbouring provinces and the national picture, brings focus to areas of opportunity.

Rich in statistics and charts, this new report from Espicom, Understanding Regional Chinese Health Markets is the first in a series on major markets; taking you further into understanding the dynamic Chinese regional health environments.

China represents 31 discrete regional markets, each with provision and needs…
China has been a focus of interest for international business for such a long time now that it has become easy to assess markets and economic performance in national terms. Even the much discussed and fast developing urban areas such as Beijing, Shanghai and Tianjin are representative of only a fraction of the widely diverse regional markets to be found elsewhere in the country.

Urban vs. Rural
Understanding the urban/rural divide in China is critical. The number of cities with over a million inhabitants is significant in every province, with migration from rural areas driven by the boom in manufacturing. The economic strength of cities over rural areas has led to an imbalance of health provision; an imbalance the Chinese government is keen to correct through mechanisms such as the New Co-operative Medical System.

This new report provides a new level of market detail
Understanding Regional Chinese Health Markets lets you drill down into the Chinese regional markets to make a practical evaluation of opportunity and risk. Whether you are manufacturing or distributing medical products locally, working through agents or just assessing the potential, this fascinating report is a must-have resource “to fully understand” the variable regional market environments in China.

A case in point – Anhui Province: The rural challenge
Anhui Province has 61.3 million people – 4.6% of the national population. The capital and largest city is Hefei, with a population of around 3.4 million and other major cities include Huainan (1.9 million), Huangshan (1.5 million) and Ma’anshan (1.4 million). The province is largely agricultural, with 35.5 million people classed as rural. Anhui has one of the lowest GDP per capita rates in the country and in 2009, it had a GDP of US$147.3 billion, equal to 2.8% of national GDP.

Anhui has below average rates of hospital beds, physicians and nurses, which can be attributed to the province’s low GDP per capita rate and large rural population. Health is delivered via a bewildering array of services including 17,788 village clinics, 1,714 health centres and 710 hospitals, of which 489 are general and 125 are specialist facilities.

Anhui is lacking in terms of healthcare workforce, with below national average rates for physicians (1.0 per ‘000) and nurses (1.1 per ‘000). However, the rural nature of the province is reflected in the higher than national average rate of village doctors, at 0.9 per ‘000 population.

Also Available…
Detailed quarterly-updated analysis of the Chinese medtech market, please click on the link for more information on
The Medical Device Market: China

For more information kindly visit :
Report on Understanding Regional Chinese Health Markets

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
http://3marketresearchreport.blogspot.in/

Report on Understanding India’s Regional Health Markets

Understanding India’s Regional Health Markets lets you explore regional Indian markets to make a practical evaluation of opportunity and risk. Whether you are manufacturing or distributing locally, working through subsidiaries/partners or just assessing the potential, this fascinating report is a must-have resource to fully appreciate the diverse regional health environments in India.

Identifying opportunities in India’s rapidly expanding health economy requires detailed knowledge of the economic performance, health infrastructure and health personnel distribution at a state/territory level. Being able to see that in the context of neighbouring provinces and the national picture brings focus to areas of opportunity and need.

Any assessment of India’s health provision must consider the huge variations to be found in such a geographically diverse country where the population is distributed over 644,278 cities, towns and villages. Key questions asked and answered by this report include:

How is the population and wealth distributed?
Which states and territories produce the highest levels of GDP?
What is the primary and secondary health infrastructure in each region?
How is healthcare delivered?
What is the role played by private/government health provision at state level?
Which regions are better provided for and which still need investment?

Rich in statistics, charts and maps, this new 110-page report Understanding Regional Indian Health Markets takes you further into understanding the dynamic Indian regional health sector. A comprehensive introduction sets the national scene while summary data for each state/territory highlights the key economic characteristics and health infrastructure. Comparative statistics are provided for each state/territory and can be seen in the light of national averages.

Setting the scene
India’s 1.21 billion population is distributed across 35 states and union territories, and is growing at 1.6% a year. In terms of landmass, India is approximately one third the size of the USA. India has an established mainly urban middle class but the bulk of the rest of the population have little by way of income and resources.

As with many emerging markets a divide is opening up between the urban and rural population. This is exacerbated in India where, despite there being over 45 cities with more than 1 million inhabitants, the majority of the population live rurally in over 638,000 villages – many of them remote and difficult to access. The impact on key health indicators, such as infant mortality, can be clearly seen and despite per capita health spending more than doubling in the last 10 years there is some way to go.

Government health spending has not kept pace with private expenditure with health insurance covering no more than 5%. Out of pocket funding of healthcare remains dominant and the growing number of middle classes have been influential in the growth and success of the many private hospital groups.

Compare and Contrast: Haryana and Rajasthan: The Indian market is one of great diversity, and the gap between the ‘haves’ and ‘have nots’ is stark. Consider the following comparisons of selected statistics between the two neighbouring north western states of Haryana and Rajasthan which have dramatically different economic drivers.

Information
Population
GDP
GDP per capita
Birth rate per 000
Infant mortality per 000 live births
Urban rate
Rural rate

National
1,210,193,000
US$1,049 billion
US$1017
22.1
47
31
51

Haryana
25,353,000
US$42.8 billion
US$1723
22.3
48
38
51

Rajasthan
68,621,000
US$49.5 billion
US$748
26.7
55
55
31

For more information kindly visit :
Report on Understanding India’s Regional Health Markets

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
http://3marketresearchreport.blogspot.in/

Research Report on World Medical Market Forecasts

The global market for medical equipment and supplies as defined in this report is valued at US$307.7 billion in 2012, equal to just under US$50 per capita. Several years of rapid growth came to a halt amid the economic downturn towards the end of 2008 and into 2009. Many countries experienced a slowdown in the market in 2009, with especially poor performance in the USA and Europe. Much of the world has seen a swift return to growth in 2010 and 2011, however, with the major exception of the Eurozone, which continues to perform relatively poorly.

The CAGR for the 2007-2011 period was 7.9%, although this masks the major reduction in growth which occurred in 2009 and 2010. Market growth resumed in 2011, although it will not be quite as rapid as before the economic downturn. Espicom projects that the total market will rise to US$434.4 billion by 2017, equal to just underUS$67 per capita and a CAGR for the 2012-17 period of 7.1%. Some of the best prospects for growth will be in the developing markets of Asia, Latin America and Central/Eastern Europe, while traditional Western markets represent more steady performers.

Use this new report to easily answer questions such as:
Which Asian countries offer the best opportunities for market growth and in which sectors?
Which Eurozone medical sector is set to exceed US$32 billion and a 2012-17 CAGR of 7%?
What are the prospects for MRI in Latin America and which countries offer the best opportunities?
How did the Chinese orthopaedic sector fare in 2011 and what are its prospects to 2017?

This important business evaluation provides:
Growth forecasts to 2017 for 86 markets – 20 more than last edition
Comparative data on a regional and global basis
Rankings by key indicators allow “at a glance” benchmarking of countries
Detailed information on each market
This report is available in pdf or print formats with Espicom Interactive web access for all customers
Practical value as all tables and graphs can be easily exported to be included in your own reports and data sets

This new report provides detailed market forecasts
Worldwide Medical Markets Forecasts to 2017 is essential for business forecasters, marketing planners and the investment community. Anyone, in fact, who needs to understand the future outlook for the dynamic medical device and equipment industry.

In 416 information-packed pages the report provides thousands of market projections, rankings and comparisons.

Provided with global, regional and national views
A global overview of key rankings

Six regional sections allow comparative assessment of countries within a geographic region:
Western Europe
Central & Eastern Europe
Middle East/Africa
Asia/Pacific
Americas
Sub Saharan Africa
Individual markets to provide detail and forecasts at a national level

For more information kindly visit :
Research Report on World Medical Market Forecasts

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
http://twitter.com/#!/bharatbook
http://retailmarketresearch.blogspot.com/

Tag Cloud